https://navidsobhani.owlstown.net https://navidsobhani.owlstown.net/publications https://navidsobhani.owlstown.net/projects https://navidsobhani.owlstown.net/people https://navidsobhani.owlstown.net/courses https://navidsobhani.owlstown.net/posts https://navidsobhani.owlstown.net/pages https://navidsobhani.owlstown.net/cv https://navidsobhani.owlstown.net/contact_form https://navidsobhani.owlstown.net/publications/56561-immune-biomarkers-for-head-and-neck-cancer https://navidsobhani.owlstown.net/publications/61758-the-double-edged-sword-role-of-tumor-associated-macrophages-preventing-or-causing-resistance-to-immunotherapy https://navidsobhani.owlstown.net/publications/44114-cd47-as-a-potent-target-in-cancer-immunotherapy-a-review https://navidsobhani.owlstown.net/publications/53482-cdk8-remodels-the-tumor-microenvironment-to-resist-the-therapeutic-efficacy-of-targeted-kras-g12d-inhibition-in-pancreatic-ductal-adenocarcinoma https://navidsobhani.owlstown.net/publications/44117-current-understanding-of-peak-family-members-in-regulation-of-cellular-signaling-pathways-and-cancer-therapy https://navidsobhani.owlstown.net/publications/44116-circulating-cell-free-dna-integrity-for-breast-and-prostate-cancer-what-is-the-landscape-for-clinical-management-of-the-most-common-cancers-in-women-and-men https://navidsobhani.owlstown.net/publications/56560-ai-based-cancer-models-in-oncology-from-diagnosis-to-adc-drug-prediction https://navidsobhani.owlstown.net/publications/44115-recent-anti-krasg12d-therapies-a-possible-impossibility-for-pancreatic-ductal-adenocarcinoma https://navidsobhani.owlstown.net/publications/56559-current-trends-in-liquid-biopsy-tracking-resistance-in-molecular-breast-cancer-targeted-therapies https://navidsobhani.owlstown.net/publications/30322-the-next-generation-dna-vaccine-platforms-and-delivery-systems-advances-challenges-and-prospects https://navidsobhani.owlstown.net/publications/39548-patient-derived-organoids-a-game-changer-in-personalized-cancer-medicine https://navidsobhani.owlstown.net/publications/37451-regulation-of-cellular-signaling-pathways-by-mammalian-proteins-containing-bacterial-epiya-or-epiya-like-motifs-predicted-to-be-phosphorylated https://navidsobhani.owlstown.net/publications/41798-investigation-of-mesenchymal-stem-cell-secretome-on-breast-cancer-gene-expression-a-bioinformatic-approach-to-identify-differentially-expressed-genes-functional-networks-and-potential-therapeutic-targets https://navidsobhani.owlstown.net/publications/39550-exploring-the-dichotomy-of-the-mesenchymal-stem-cell-secretome-implications-for-tumor-modulation-via-cell-signaling-pathways https://navidsobhani.owlstown.net/publications/37449-future-ai-will-most-likely-predict-antibody-drug-conjugate-response-in-oncology-a-review-and-expert-opinion https://navidsobhani.owlstown.net/publications/30321-artificial-intelligence-powered-discovery-of-small-molecules-inhibiting-ctla-4-in-cancer https://navidsobhani.owlstown.net/publications/23336-immune-related-pan-cancer-gene-expression-signatures-of-patient-survival-revealed-by-nanostring-based-analyses https://navidsobhani.owlstown.net/publications/24750-epithelioid-mesothelioma-patients-with-very-long-survival-display-defects-in-dna-repair https://navidsobhani.owlstown.net/publications/24192-the-co-delivery-of-adenovirus-based-immune-checkpoint-vaccine-elicits-a-potent-anti-tumor-effect-in-renal-carcinoma https://navidsobhani.owlstown.net/publications/23380-the-power-of-whole-genomic-sequencing-in-biomedical-research-and-clinical-applications https://navidsobhani.owlstown.net/publications/24749-cancer-management-during-the-covid-19-world-pandemic https://navidsobhani.owlstown.net/publications/25086-biomarkers-of-prediction-of-immunotherapy-and-updates-on-ctla-4-therapy https://navidsobhani.owlstown.net/publications/23335-analysis-of-pd-l1-and-cd3-expression-in-glioblastoma-patients-and-correlation-with-outcome-a-single-center-report https://navidsobhani.owlstown.net/publications/23333-comparison-of-dna-vaccines-with-as03-as-an-adjuvant-and-an-mrna-vaccine-against-sars-cov-2 https://navidsobhani.owlstown.net/publications/23334-hmgb1-gpc3-dual-targeting-vaccine-induces-dendritic-cells-mediated-cd8-t-cell-immune-response-and-elicits-potential-therapeutic-effect-in-hepatocellular-carcinoma https://navidsobhani.owlstown.net/publications/23339-clinico-immunological-effects-of-a-single-agent-cdk4-6-inhibitor-in-advanced-hr-her2-breast-cancer-based-on-a-window-of-opportunity-study https://navidsobhani.owlstown.net/publications/23340-an-update-on-antibody-drug-conjugates-in-urothelial-carcinoma-state-of-the-art-strategies-and-what-comes-next https://navidsobhani.owlstown.net/publications/23345-ifi35-promotes-renal-cancer-progression-by-inhibiting-pstat1-pstat6-dependent-autophagy https://navidsobhani.owlstown.net/publications/23338-the-role-of-genomics-and-proteomics-in-lung-cancer-early-detection-and-treatment https://navidsobhani.owlstown.net/publications/23341-therapeutic-cancer-vaccines-from-biological-mechanisms-and-engineering-to-ongoing-clinical-trials https://navidsobhani.owlstown.net/publications/23342-predictive-and-prognostic-value-of-non-coding-rna-in-breast-cancer https://navidsobhani.owlstown.net/publications/23337-c1qbp-regulates-mitochondrial-plasticity-to-impact-tumor-progression-and-antitumor-immune-response https://navidsobhani.owlstown.net/publications/23350-cancer-testis-antigens-from-serology-to-mrna-cancer-vaccine https://navidsobhani.owlstown.net/publications/23353-advances-in-anti-braf-therapies-for-lung-cancer https://navidsobhani.owlstown.net/publications/23355-targeting-aberrant-fgfr-signaling-to-overcome-cdk4-6-inhibitor-resistance-in-breast-cancer https://navidsobhani.owlstown.net/publications/23352-ctla-4-in-regulatory-t-cells-for-cancer-immunotherapy https://navidsobhani.owlstown.net/publications/23347-p53-antibodies-as-a-diagnostic-marker-for-cancer-a-meta-analysis https://navidsobhani.owlstown.net/publications/23349-ar-v7-in-metastatic-prostate-cancer-a-strategy-beyond-redemption https://navidsobhani.owlstown.net/publications/23346-immunotherapeutic-treatments-in-hepatocellular-carcinoma-achievements-challenges-and-future-prospects https://navidsobhani.owlstown.net/publications/23357-focus-on-ros1-positive-non-small-cell-lung-cancer-nsclc-crizotinib-resistance-mechanisms-and-the-newer-generation-of-targeted-therapies https://navidsobhani.owlstown.net/publications/23363-cabozantinib-as-a-second-line-treatment-option-in-hepatocellular-carcinoma https://navidsobhani.owlstown.net/publications/23359-immune-system-and-angiogenesis-related-potential-surrogate-biomarkers-of-response-to-everolimus-based-treatment-in-hormone-receptor-positive-breast-cancer-an-exploratory-study https://navidsobhani.owlstown.net/publications/23365-corticosteroid-switch-after-progression-on-abiraterone-acetate-plus-prednisone https://navidsobhani.owlstown.net/publications/23356-early-changes-of-the-standardized-uptake-values-suvmax-predict-the-efficacy-of-everolimus-exemestane-in-patients-with-hormone-receptor-positive-metastatic-breast-cancer https://navidsobhani.owlstown.net/publications/23361-mutant-p53-as-an-antigen-in-cancer-immunotherapy https://navidsobhani.owlstown.net/publications/23358-circulating-cell-free-nucleic-acids-as-prognostic-and-therapy-predictive-tools-for-metastatic-castrate-resistant-prostate-cancer https://navidsobhani.owlstown.net/publications/23362-immune-gene-signature-a-new-tool-for-patient-selection-for-checkpoint-inhibitors https://navidsobhani.owlstown.net/publications/23360-mr1-restricted-t-cells-in-cancer-immunotherapy https://navidsobhani.owlstown.net/publications/23364-the-fibroblast-growth-factor-receptors-in-breast-cancer-from-oncogenesis-to-better-treatments https://navidsobhani.owlstown.net/publications/23366-tumour-infiltrating-lymphocytes-and-immune-related-genes-as-predictors-of-outcome-in-pancreatic-adenocarcinoma https://navidsobhani.owlstown.net/publications/23367-avelumab-in-gastric-cancer https://navidsobhani.owlstown.net/publications/23370-the-combination-of-bevacizumab-with-chemotherapy-is-more-beneficial-in-the-metastatic-setting-rather-than-in-the-adjuvant-setting-for-the-treatment-of-her2-negative-breast-cancer-a-commentary-on-the-e5103-randomized-phase-iii-clinical-study https://navidsobhani.owlstown.net/publications/23368-updates-on-the-cdk4-6-inhibitory-strategy-and-combinations-in-breast-cancer https://navidsobhani.owlstown.net/publications/23373-lenvatinib-for-the-treatment-of-renal-cell-carcinoma https://navidsobhani.owlstown.net/publications/23372-current-status-of-fibroblast-growth-factor-receptor-targeted-therapies-in-breast-cancer https://navidsobhani.owlstown.net/publications/23374-current-status-of-androgen-receptor-splice-variant-7-inhibitor-niclosamide-in-castrate-resistant-prostate-cancer https://navidsobhani.owlstown.net/publications/23371-current-status-of-pi3k-mtor-inhibition-in-hormone-receptor-positive-her2-negative-breast-cancer https://navidsobhani.owlstown.net/publications/23375-the-prognostic-value-of-pi3k-mutational-status-in-breast-cancer-a-meta-analysis https://navidsobhani.owlstown.net/publications/23377-bevacizumab-in-small-cell-lung-cancer https://navidsobhani.owlstown.net/publications/23788-c32efficacy-of-extended-aromatase-inhibitors-for-hormone-receptor-positive-breast-cancer-a-literature-based-meta-analysis-of-randomized-trials https://navidsobhani.owlstown.net/publications/23378-pak6-associated-support-vector-machine-classifier-a-new-way-to-evaluate-response-and-survival-of-gastric-cancer-treated-by-5-fu-oxaliplatin-chemotherapy https://navidsobhani.owlstown.net/publications/23376-advances-in-systemic-therapy-for-malignant-mesothelioma-future-perspectives https://navidsobhani.owlstown.net/publications/23379-cyclin-dependent-kinase-4-and-6-inhibitors-as-novel-therapeutic-agents-for-targeted-treatment-of-malignant-mesothelioma https://navidsobhani.owlstown.net/posts/1898-comment-on-my-elsevier-book-chapter-the-power-of-whole-genomic-sequencing-in-biomedical-research-and-clinical-applications https://navidsobhani.owlstown.net/posts/1899-comment-on-my-co-authored-study-epithelioid-mesothelioma-patients-with-very-long-survival-display-defects-in-dna-repair https://navidsobhani.owlstown.net/posts/1900-comment-on-my-npj-co-authored-article-the-co-delivery-of-adenovirus-based-immune-checkpoint-vaccine-elicits-a-potent-anti-tumor-effect-in-renal-carcinoma https://navidsobhani.owlstown.net/posts/1901-comment-of-my-review-on-cancer-management-during-the-covid-19-world-pandemic https://navidsobhani.owlstown.net/posts/1902-comment-on-my-nature-book-chapter-biomarkers-of-prediction-of-immunotherapy-and-updates-on-ctla-4-therapy https://navidsobhani.owlstown.net/posts/1903-comment-on-my-study-analysis-of-pd-l1-and-cd3-expression-in-glioblastoma-patients-and-correlation-with-outcome-a-single-center-report https://navidsobhani.owlstown.net/posts/1904-comment-on-my-bioinformatic-paper-p53-antibodies-as-a-diagnostic-marker-for-cancer-a-meta-analysis https://navidsobhani.owlstown.net/posts/1905-comment-on-co-authored-study-immune-system-and-angiogenesis-related-potential-surrogate-biomarkers-of-response-to-everolimus-based-treatment-in-hormone-receptor-positive-breast-cancer-an-exploratory-study https://navidsobhani.owlstown.net/posts/1906-comment-on-my-co-athored-study-tumour-infiltrating-lymphocytes-and-immune-related-genes-as-predictors-of-outcome-in-pancreatic-adenocarcinoma https://navidsobhani.owlstown.net/posts/1907-comment-on-my-study-tumour-infiltrating-lymphocytes-and-pd-l1-expression-as-potential-predictors-of-outcome-in-patients-with-malignant-pleural-mesothelioma https://navidsobhani.owlstown.net/posts/1908-comment-on-my-bioinformatics-paper-the-prognostic-value-of-pi3k-mutational-status-in-breast-cancer-a-meta-analysis